These studies suggested that acylated and desacylated ghrelin had neuroprotective properties in experimental models of stroke when administered before induction of cerebral ischemia or shortly after induction of reperfusion [23, 24, 26, 29, 30]. The gene discussed is GHRL; the disease is brain ischemia.